Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, De Sèze J, Vukusic S, Honnorat J, Confavreux C; NOMADMUS Study Group..

Neurology. 2013 Jun 11;80(24):2194-200. doi: 10.1212/WNL.0b013e318296e917.

PMID:
23658379
2.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Küker W, Chandratre S, Vincent A, Palace J.

JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.

PMID:
24425068
3.

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Ishii N, Itoyama Y.

Tohoku J Exp Med. 2006 Dec;210(4):307-13.

4.

Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.

Kim W, Lee JE, Li XF, Kim SH, Han BG, Lee BI, Kim JK, Choi K, Kim HJ.

Mult Scler. 2012 May;18(5):578-86. doi: 10.1177/1352458511424590.

PMID:
21965418
5.

Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

Kitley J, Leite MI, Küker W, Quaghebeur G, George J, Waters P, Woodhall M, Vincent A, Palace J.

JAMA Neurol. 2013 Nov;70(11):1375-81. doi: 10.1001/jamaneurol.2013.3890.

PMID:
23999580
6.

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.

Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G.

Mult Scler. 2009 Oct;15(10):1153-63. doi: 10.1177/1352458509106851.

PMID:
19667009
7.

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.

Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP.

J Neurol Sci. 2010 Apr 15;291(1-2):52-6. doi: 10.1016/j.jns.2010.01.002.

PMID:
20117794
8.

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.

Jarius S, Wildemann B.

Brain Pathol. 2013 Nov;23(6):661-83. doi: 10.1111/bpa.12084. Review.

PMID:
24118483
9.

Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity.

Pisani F, Sparaneo A, Tortorella C, Ruggieri M, Trojano M, Mola MG, Nicchia GP, Frigeri A, Svelto M.

PLoS One. 2013 Nov 15;8(11):e79185. doi: 10.1371/journal.pone.0079185.

10.

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M.

Neurology. 2013 Jun 11;80(24):2210-6. doi: 10.1212/WNL.0b013e318296ea08.

PMID:
23677744
11.

[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].

Yang Y, Wu WP, Huang DH, Wu L.

Zhonghua Yi Xue Za Zhi. 2012 Nov 20;92(43):3032-5. Chinese.

PMID:
23328372
12.

Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.

Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W, Berger T, Reindl M.

PLoS One. 2010 May 5;5(5):e10455. doi: 10.1371/journal.pone.0010455.

13.

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.

Kim YJ, Jung SW, Kim Y, Park YJ, Han K, Oh EJ.

J Clin Lab Anal. 2012 May;26(3):184-9. doi: 10.1002/jcla.21508.

PMID:
22628234
14.

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.

Jarius S, Paul F, Fechner K, Ruprecht K, Kleiter I, Franciotta D, Ringelstein M, Pache F, Aktas O, Wildemann B.

J Neuroinflammation. 2014 Jul 29;11:129. doi: 10.1186/1742-2094-11-129.

15.

Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.

Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, Ringelstein M, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2012 Sep 15;320(1-2):32-7. doi: 10.1016/j.jns.2012.06.002.

PMID:
22705047
16.

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F.

PLoS Med. 2007 Apr;4(4):e133.

17.

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.

Kim SM, Waters P, Woodhall M, Kim JY, Kim JE, Yang JW, Kim JS, Sung JJ, Park KS, Lee KW.

Mult Scler. 2013 Jul;19(8):1060-7. doi: 10.1177/1352458512472748.

PMID:
23329699
18.

Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays.

Chan KH, Kwan JS, Ho PW, Ho JW, Chu AC, Ramsden DB.

J Neuroinflammation. 2010 Sep 7;7:50. doi: 10.1186/1742-2094-7-50.

19.

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.

Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W.

Brain. 2008 Nov;131(Pt 11):3072-80. doi: 10.1093/brain/awn240.

20.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.

Brain. 2007 May;130(Pt 5):1235-43.

PMID:
17449477

Supplemental Content

Support Center